Heart Failure – Large Market Opportunities for New Biomarkers

As part of broader healthcare reform, not just under the ACA (Obamacare), there has been an emphasis on quality of care for prevention. The number one diagnosis for 30-day readmission to hospitals is heart failure (HF). This is compounded by 6 million patients with HF. Consequently, there is a lot of focus, and momentum to… Read More Heart Failure – Large Market Opportunities for New Biomarkers